nodes	percent_of_prediction	percent_of_DWPC	metapath
Salmeterol—CYP3A4—chronic kidney failure	0.807	1	CbGaD
Salmeterol—Salbutamol—CYP3A4—chronic kidney failure	0.00116	0.494	CrCbGaD
Salmeterol—Propafenone—CYP3A4—chronic kidney failure	0.000646	0.276	CrCbGaD
Salmeterol—Propafenone—ABCB1—chronic kidney failure	0.000538	0.23	CrCbGaD
Salmeterol—CYP3A7—Metabolism—SLC22A2—chronic kidney failure	0.000122	0.000643	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—EDN1—chronic kidney failure	0.000122	0.000641	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	0.000121	0.000637	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCL5—chronic kidney failure	0.000121	0.000636	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—FABP1—chronic kidney failure	0.00012	0.00063	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	0.000119	0.000623	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	0.000116	0.00061	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—PTH—chronic kidney failure	0.000115	0.000602	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ABCG1—chronic kidney failure	0.000114	0.000598	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GATM—chronic kidney failure	0.000114	0.000598	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—AGXT—chronic kidney failure	0.000114	0.000598	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—chronic kidney failure	0.000112	0.000588	CbGpPWpGaD
Salmeterol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	0.000111	0.000585	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PIP5K1B—chronic kidney failure	0.000111	0.000585	CbGpPWpGaD
Salmeterol—CYP2C8—Biological oxidations—POMC—chronic kidney failure	0.00011	0.000579	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—NPY—chronic kidney failure	0.00011	0.000576	CbGpPWpGaD
Salmeterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL2—chronic kidney failure	0.00011	0.000575	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ARG2—chronic kidney failure	0.000109	0.000573	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCR5—chronic kidney failure	0.000109	0.000573	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—LCAT—chronic kidney failure	0.000107	0.000562	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CRH—chronic kidney failure	0.000106	0.000555	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—OXT—chronic kidney failure	0.000106	0.000555	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—COL4A5—chronic kidney failure	0.000105	0.000552	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ACAT1—chronic kidney failure	0.000104	0.000547	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—FABP1—chronic kidney failure	0.000104	0.000546	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—NPS—chronic kidney failure	0.0001	0.000527	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—NPY—chronic kidney failure	9.95e-05	0.000523	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	9.88e-05	0.000519	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GATM—chronic kidney failure	9.85e-05	0.000518	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—AGXT—chronic kidney failure	9.85e-05	0.000518	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—DRD1—chronic kidney failure	9.83e-05	0.000516	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—DDC—chronic kidney failure	9.82e-05	0.000516	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TFDP2—chronic kidney failure	9.77e-05	0.000513	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MLXIPL—chronic kidney failure	9.67e-05	0.000508	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	9.63e-05	0.000506	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	9.63e-05	0.000506	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—OXT—chronic kidney failure	9.6e-05	0.000504	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CRH—chronic kidney failure	9.6e-05	0.000504	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PIP5K1B—chronic kidney failure	9.56e-05	0.000502	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP2B6—chronic kidney failure	9.54e-05	0.000501	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PRKD1—chronic kidney failure	9.54e-05	0.000501	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PRKAG2—chronic kidney failure	9.54e-05	0.000501	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—F2—chronic kidney failure	9.36e-05	0.000491	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—NPS—chronic kidney failure	9.1e-05	0.000478	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ACAT1—chronic kidney failure	9.01e-05	0.000473	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—SREBF2—chronic kidney failure	8.93e-05	0.000469	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—DRD1—chronic kidney failure	8.93e-05	0.000469	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	8.9e-05	0.000467	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SLC22A2—chronic kidney failure	8.85e-05	0.000465	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	8.81e-05	0.000463	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PGF—chronic kidney failure	8.71e-05	0.000457	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	8.64e-05	0.000454	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—GCKR—chronic kidney failure	8.62e-05	0.000453	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ABCC3—chronic kidney failure	8.62e-05	0.000453	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—POMC—chronic kidney failure	8.52e-05	0.000448	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—LPIN1—chronic kidney failure	8.44e-05	0.000443	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	8.4e-05	0.000441	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MLXIPL—chronic kidney failure	8.38e-05	0.00044	CbGpPWpGaD
Salmeterol—ADRB2—GPCR ligand binding—CCL2—chronic kidney failure	8.34e-05	0.000438	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP2C18—chronic kidney failure	8.27e-05	0.000434	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—LRP2—chronic kidney failure	8.27e-05	0.000434	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ABCG1—chronic kidney failure	8.23e-05	0.000432	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	8.22e-05	0.000432	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PRKAG2—chronic kidney failure	8.18e-05	0.00043	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PIP5K1B—chronic kidney failure	8.05e-05	0.000423	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—CYP1A1—chronic kidney failure	7.93e-05	0.000417	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ARG2—chronic kidney failure	7.89e-05	0.000414	CbGpPWpGaD
Salmeterol—CYP3A4—Metapathway biotransformation—CYP1A1—chronic kidney failure	7.83e-05	0.000411	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—COL4A3—chronic kidney failure	7.76e-05	0.000407	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LCAT—chronic kidney failure	7.73e-05	0.000406	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SLC22A2—chronic kidney failure	7.66e-05	0.000402	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—HBEGF—chronic kidney failure	7.59e-05	0.000399	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	7.49e-05	0.000393	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CRHR1—chronic kidney failure	7.4e-05	0.000389	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—AVP—chronic kidney failure	7.25e-05	0.000381	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ABCG1—chronic kidney failure	7.12e-05	0.000374	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—DDC—chronic kidney failure	7.1e-05	0.000373	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LRP2—chronic kidney failure	7.1e-05	0.000373	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CPT1A—chronic kidney failure	7.03e-05	0.000369	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PIP5K1B—chronic kidney failure	6.97e-05	0.000366	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—EDN1—chronic kidney failure	6.89e-05	0.000362	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PRKAG2—chronic kidney failure	6.89e-05	0.000362	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP2B6—chronic kidney failure	6.89e-05	0.000362	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PRKD1—chronic kidney failure	6.89e-05	0.000362	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—LIPC—chronic kidney failure	6.85e-05	0.00036	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP2C19—chronic kidney failure	6.85e-05	0.00036	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CCL5—chronic kidney failure	6.84e-05	0.000359	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ARG2—chronic kidney failure	6.83e-05	0.000359	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—PTH—chronic kidney failure	6.77e-05	0.000356	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LCAT—chronic kidney failure	6.7e-05	0.000352	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CYBB—chronic kidney failure	6.6e-05	0.000346	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—AVP—chronic kidney failure	6.58e-05	0.000346	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SREBF2—chronic kidney failure	6.45e-05	0.000339	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—SCARB1—chronic kidney failure	6.33e-05	0.000332	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PTGS1—chronic kidney failure	6.27e-05	0.000329	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—EDN1—chronic kidney failure	6.26e-05	0.000329	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—FGF23—chronic kidney failure	6.25e-05	0.000328	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—GCKR—chronic kidney failure	6.23e-05	0.000327	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ABCC3—chronic kidney failure	6.23e-05	0.000327	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCL5—chronic kidney failure	6.21e-05	0.000326	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—CCR5—chronic kidney failure	6.16e-05	0.000324	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—DDC—chronic kidney failure	6.15e-05	0.000323	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—SREBF1—chronic kidney failure	6.15e-05	0.000323	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LPIN1—chronic kidney failure	6.1e-05	0.00032	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—HMGCR—chronic kidney failure	5.98e-05	0.000314	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LRP2—chronic kidney failure	5.98e-05	0.000314	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP2C18—chronic kidney failure	5.98e-05	0.000314	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP2B6—chronic kidney failure	5.97e-05	0.000314	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PRKD1—chronic kidney failure	5.97e-05	0.000314	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PRKAG2—chronic kidney failure	5.97e-05	0.000314	CbGpPWpGaD
Salmeterol—CYP3A4—Biological oxidations—POMC—chronic kidney failure	5.92e-05	0.000311	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NPY—chronic kidney failure	5.88e-05	0.000309	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	5.88e-05	0.000309	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—FASN—chronic kidney failure	5.85e-05	0.000307	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	5.68e-05	0.000298	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CRH—chronic kidney failure	5.67e-05	0.000298	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—OXT—chronic kidney failure	5.67e-05	0.000298	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCR5—chronic kidney failure	5.6e-05	0.000294	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SREBF2—chronic kidney failure	5.59e-05	0.000294	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—FABP1—chronic kidney failure	5.58e-05	0.000293	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NCF1—chronic kidney failure	5.43e-05	0.000285	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP3A4—chronic kidney failure	5.42e-05	0.000285	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—GCKR—chronic kidney failure	5.4e-05	0.000284	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ABCC3—chronic kidney failure	5.4e-05	0.000284	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NPS—chronic kidney failure	5.38e-05	0.000282	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ABCA1—chronic kidney failure	5.33e-05	0.00028	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—AGXT—chronic kidney failure	5.29e-05	0.000278	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GATM—chronic kidney failure	5.29e-05	0.000278	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—F2—chronic kidney failure	5.29e-05	0.000278	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LPIN1—chronic kidney failure	5.28e-05	0.000278	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—DRD1—chronic kidney failure	5.27e-05	0.000277	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	5.19e-05	0.000273	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LRP2—chronic kidney failure	5.18e-05	0.000272	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP2C18—chronic kidney failure	5.18e-05	0.000272	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CYBA—chronic kidney failure	5.11e-05	0.000268	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CPT1A—chronic kidney failure	5.08e-05	0.000267	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP2C19—chronic kidney failure	4.95e-05	0.00026	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LIPC—chronic kidney failure	4.95e-05	0.00026	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ACAT1—chronic kidney failure	4.84e-05	0.000254	CbGpPWpGaD
Salmeterol—ADRB2—GPCR downstream signaling—POMC—chronic kidney failure	4.82e-05	0.000253	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—F2—chronic kidney failure	4.8e-05	0.000252	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SCARB1—chronic kidney failure	4.58e-05	0.00024	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PTGS1—chronic kidney failure	4.53e-05	0.000238	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CAT—chronic kidney failure	4.51e-05	0.000237	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MLXIPL—chronic kidney failure	4.5e-05	0.000236	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—HBEGF—chronic kidney failure	4.48e-05	0.000236	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—SREBF1—chronic kidney failure	4.44e-05	0.000233	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CPT1A—chronic kidney failure	4.4e-05	0.000231	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ABCB1—chronic kidney failure	4.39e-05	0.00023	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—POMC—chronic kidney failure	4.37e-05	0.00023	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—HMGCR—chronic kidney failure	4.32e-05	0.000227	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP2C19—chronic kidney failure	4.29e-05	0.000225	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LIPC—chronic kidney failure	4.29e-05	0.000225	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—CCL2—chronic kidney failure	4.28e-05	0.000225	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	4.23e-05	0.000222	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—FASN—chronic kidney failure	4.23e-05	0.000222	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—LPL—chronic kidney failure	4.18e-05	0.00022	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	4.11e-05	0.000216	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—CYP1A1—chronic kidney failure	4.04e-05	0.000212	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SCARB1—chronic kidney failure	3.96e-05	0.000208	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PTGS1—chronic kidney failure	3.92e-05	0.000206	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP3A4—chronic kidney failure	3.92e-05	0.000206	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—AVP—chronic kidney failure	3.89e-05	0.000204	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	3.86e-05	0.000203	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ABCA1—chronic kidney failure	3.85e-05	0.000202	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—SREBF1—chronic kidney failure	3.85e-05	0.000202	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ABCG1—chronic kidney failure	3.82e-05	0.000201	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—MTHFR—chronic kidney failure	3.76e-05	0.000198	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—HMGCR—chronic kidney failure	3.74e-05	0.000197	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	3.74e-05	0.000197	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—EDN1—chronic kidney failure	3.7e-05	0.000194	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PPARA—chronic kidney failure	3.69e-05	0.000194	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL5—chronic kidney failure	3.67e-05	0.000193	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ARG2—chronic kidney failure	3.67e-05	0.000193	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—FASN—chronic kidney failure	3.66e-05	0.000192	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LCAT—chronic kidney failure	3.6e-05	0.000189	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—LPL—chronic kidney failure	3.59e-05	0.000188	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NGF—chronic kidney failure	3.4e-05	0.000178	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP3A4—chronic kidney failure	3.39e-05	0.000178	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	3.38e-05	0.000177	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ABCA1—chronic kidney failure	3.34e-05	0.000175	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCR5—chronic kidney failure	3.31e-05	0.000174	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—DDC—chronic kidney failure	3.3e-05	0.000173	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CAT—chronic kidney failure	3.26e-05	0.000171	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	3.2e-05	0.000168	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	3.2e-05	0.000168	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PRKD1—chronic kidney failure	3.2e-05	0.000168	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ABCB1—chronic kidney failure	3.17e-05	0.000167	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—LPL—chronic kidney failure	3.02e-05	0.000159	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—POMC—chronic kidney failure	3.01e-05	0.000158	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SREBF2—chronic kidney failure	3e-05	0.000158	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—CYP1A1—chronic kidney failure	2.92e-05	0.000153	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ABCC3—chronic kidney failure	2.9e-05	0.000152	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—GCKR—chronic kidney failure	2.9e-05	0.000152	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—F2—chronic kidney failure	2.84e-05	0.000149	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LPIN1—chronic kidney failure	2.84e-05	0.000149	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CAT—chronic kidney failure	2.82e-05	0.000148	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LRP2—chronic kidney failure	2.78e-05	0.000146	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	2.78e-05	0.000146	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ABCB1—chronic kidney failure	2.75e-05	0.000144	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—ALB—chronic kidney failure	2.74e-05	0.000144	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—MTHFR—chronic kidney failure	2.72e-05	0.000143	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IRS1—chronic kidney failure	2.68e-05	0.000141	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PPARA—chronic kidney failure	2.67e-05	0.00014	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—NOS3—chronic kidney failure	2.63e-05	0.000138	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—LPL—chronic kidney failure	2.62e-05	0.000137	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—POMC—chronic kidney failure	2.58e-05	0.000136	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—CYP1A1—chronic kidney failure	2.53e-05	0.000133	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—CCL2—chronic kidney failure	2.53e-05	0.000133	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IGF1—chronic kidney failure	2.49e-05	0.000131	CbGpPWpGaD
Salmeterol—CYP3A7—Metabolism—PTGS2—chronic kidney failure	2.4e-05	0.000126	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CPT1A—chronic kidney failure	2.36e-05	0.000124	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—SERPINE1—chronic kidney failure	2.36e-05	0.000124	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—MTHFR—chronic kidney failure	2.36e-05	0.000124	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—KRAS—chronic kidney failure	2.34e-05	0.000123	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PPARA—chronic kidney failure	2.31e-05	0.000121	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LIPC—chronic kidney failure	2.3e-05	0.000121	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	2.3e-05	0.000121	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NOS3—chronic kidney failure	2.25e-05	0.000118	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—POMC—chronic kidney failure	2.18e-05	0.000114	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SCARB1—chronic kidney failure	2.13e-05	0.000112	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—RELA—chronic kidney failure	2.12e-05	0.000111	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PTGS1—chronic kidney failure	2.11e-05	0.000111	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—SREBF1—chronic kidney failure	2.07e-05	0.000108	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—HMGCR—chronic kidney failure	2.01e-05	0.000106	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—ALB—chronic kidney failure	1.98e-05	0.000104	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—FASN—chronic kidney failure	1.97e-05	0.000103	CbGpPWpGaD
Salmeterol—ADRB2—Signaling by GPCR—IL6—chronic kidney failure	1.9e-05	9.98e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—NOS3—chronic kidney failure	1.9e-05	9.97e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—POMC—chronic kidney failure	1.88e-05	9.9e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ABCA1—chronic kidney failure	1.79e-05	9.4e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—NFKB1—chronic kidney failure	1.79e-05	9.39e-05	CbGpPWpGaD
Salmeterol—CYP3A5—Metabolism—PTGS2—chronic kidney failure	1.74e-05	9.12e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—ALB—chronic kidney failure	1.72e-05	9.03e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—NOS3—chronic kidney failure	1.64e-05	8.63e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—VEGFA—chronic kidney failure	1.62e-05	8.53e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CAT—chronic kidney failure	1.52e-05	7.96e-05	CbGpPWpGaD
Salmeterol—CYP2C8—Metabolism—PTGS2—chronic kidney failure	1.5e-05	7.9e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—TGFB1—chronic kidney failure	1.49e-05	7.83e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ABCB1—chronic kidney failure	1.47e-05	7.74e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—LPL—chronic kidney failure	1.41e-05	7.38e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—KRAS—chronic kidney failure	1.38e-05	7.25e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	1.36e-05	7.13e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—MTHFR—chronic kidney failure	1.27e-05	6.64e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PPARA—chronic kidney failure	1.24e-05	6.52e-05	CbGpPWpGaD
Salmeterol—ADRB2—Signaling Pathways—IL6—chronic kidney failure	1.12e-05	5.9e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—POMC—chronic kidney failure	1.01e-05	5.31e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—ALB—chronic kidney failure	9.22e-06	4.84e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—NOS3—chronic kidney failure	8.82e-06	4.63e-05	CbGpPWpGaD
Salmeterol—CYP3A4—Metabolism—PTGS2—chronic kidney failure	8.07e-06	4.24e-05	CbGpPWpGaD
